Acasti Pharma Inc. appointed Dr. R. Loch Macdonald as Chief Medical Officer, Carrie D'Andrea as VP Clinical Operations, and Amresh Kumar as VP of Program Management, while terminating the employment of Brian Ford, Pierre Lemieux, and George Kottayil. The company also announced the successful submission of GTX-104's full protocol to the FDA and a strategic realignment plan to prioritize resources to GTX-104 and extend the company's cash runway.